Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ …
<!-- Name:DistributionId Value:8793824 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Candidemia
FDA Panel Backs Weekly Rezafungin for Candidemia, Invasive Candidiasis
An FDA advisory committee on Tuesday overwhelmingly recommended approval, with a "limited…
SCYNEXIS Presents Data Analyses Showing Ibrexafungerp’s Potential to Fight Invasive…
New interim analysis of the Phase 3 CARES study showed complete or partial response in 78% of the 18 patients treated with ibrexafungerp for infections caused by Candida auris, a…